LACK OF EFFECT OF SECUKINUMAB TREATMENT ON THE LIPID PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE II STUDY

被引:2
作者
Durez, P. [1 ]
Genovese, M. [2 ]
Kellner, H. [3 ]
Codding, C. [4 ]
Ligozio, G. [5 ]
Richards, H. [6 ]
Escrig, C. [6 ]
Mpofu, S. [6 ]
机构
[1] Catholic Univ Louvain, Clin Univ St Luc, B-1200 Brussels, Belgium
[2] Stanford Univ, Stanford, CA 94305 USA
[3] Ctr Inflammatory Joint Dis, Munich, Germany
[4] Hlth Res Oklahoma, Oklahoma City, OK USA
[5] Novartis Pharmaceut, E Hanover, NJ USA
[6] Novartis Pharrna AG, Basel, Switzerland
关键词
RISK;
D O I
10.1136/annrheumdis-2012-eular.2084
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:194 / 195
页数:2
相关论文
共 5 条
[1]   Risk of Cardiovascular Mortality in Patients With Rheumatoid Arthritis: A Meta-Analysis of Observational Studies [J].
Avina-Zubieta, J. Antonio ;
Choi, Hyon K. ;
Sadatsafavi, Mohsen ;
Etminan, Mahyar ;
Esdaile, John M. ;
Lacaille, Diane .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (12) :1690-1697
[2]  
Genovese Mark C., 2011, ARTHRITIS RHEUM S, V63, pS149
[3]   Total cholesterol and LDL levels decrease before rheumatoid arthritis [J].
Myasoedova, Elena ;
Crowson, Cynthia S. ;
Kremers, Hilal Maradit ;
Fitz-Gibbon, Patrick D. ;
Therneau, Terry M. ;
Gabriel, Sherine E. .
ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (07) :1310-1314
[4]   The interplay between inflammation, lipids and cardiovascular risk in rheumatoid arthritis: why ratios may be better [J].
Peters, M. J. L. ;
Voskuyl, A. E. ;
Sattar, N. ;
Dijkmans, B. A. C. ;
Smulders, Y. M. ;
Nurmohamed, M. T. .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2010, 64 (10) :1440-1443
[5]   Emerging drugs for rheumatoid arthritis [J].
Voulgari, Paraskevi V. .
EXPERT OPINION ON EMERGING DRUGS, 2008, 13 (01) :175-196